Navigation Links
Vaccine to cope with viral diversity in HIV

The ability of HIV-1 to develop high levels of genetic diversity and acquire mutations to escape immune pressures contributes to our difficulties in producing a vaccine. David Nickle et al present here an efficient algorithm to develop vaccines that cope with the diversity of HIV or other variable pathogens.

This computational method clarifies and analyzes the variation found in the strains of the virus by describing the molecules which stimulate the immune response to HIV (immunogens) that have multiple forms of variable elements of the virus. These antigens compress the variation found in many viral strains into lengths suitable for vaccine immunogens. "We can capture 62% of the variation found in the Nef protein and 81% of the variation in the Gag protein into immunogens of three gene lengths", says Nickle.

These short-length immunogens are potentially useable in a vaccine, as they reflect the diversity of features in HIV-1 strains. These immunogens should elicit immune responses against high frequency viral strains as well as against most mutant forms of the virus.
'"/>

Source:Public Library of Science


Page: 1

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. Live Recombinant Adenovirus Vaccine Technique Explored
3. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
4. NIAID Initiates Trial of Experimental Avian Flu Vaccine
5. Study Models Impact Of Anthrax Vaccine
6. New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines
7. Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy
8. EuroVacc 02 HIV Vaccine Trial Begins
9. Active Vaccine Prevents Mice From Developing Prion Disease
10. New Vaccine To Be Used For First Time In Polio Outbreak Response
11. Boosting The BCG Vaccine To Beat Tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vaccine cope with viral diversity HIV

Breaking Biology News(10 mins):Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10First-in-class treatment for acute leukemia 2First-in-class treatment for acute leukemia 3Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 1BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 2BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 3BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 4BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 5BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 6BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 7BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 8BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 9BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 10BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 11BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 1Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 28Forecast Looks Good for India Pharma Shows 6107 1Forecast Looks Good for India Pharma Shows 6107 2Forecast Looks Good for India Pharma Shows 6107 3